Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7-Reference-Cited by-同舟云学术

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7

Published:2016-10 Issue:4 Volume:70 Page:684-691
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fosså Sophie D.,Wiklund Fredrik,Klepp Olbjørn,Angelsen Anders,Solberg Arne,Damber Jan-Erik,Hoyer Morten,Widmark Anders

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer;D‘Amico;Urology,2002

2. Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study;Thomsen;Eur J Cancer,2015

3. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomized phase III trial;Widmark;Lancet,2009

4. Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer;Mason;J Clin Oncol,2015

5. Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: An open randomized phase 3 trial;Mottet;Eur Urol,2012

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer;Current Urology Reports;2024-06-11

2. Differences in real‐world outcomes by risk classification for localized prostate cancer patients after radiation therapy;The Prostate;2024-04-29

3. Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancer;Scientific Reports;2024-04-08

4. Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non‐metastatic high‐risk prostate cancer (SPCG 19/GRand‐P);BJU International;2024-03-12

5. Approach to Patients with High-Risk Localized Prostate Cancer: Radiation Oncology Perspective;Current Treatment Options in Oncology;2024-01